These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20592720)

  • 1. Improving productivity with model-based drug development: an enterprise perspective.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2010 Aug; 88(2):263-8. PubMed ID: 20592720
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacometrics and the transition to model-based development.
    Grasela TH; Dement CW; Kolterman OG; Fineman MS; Grasela DM; Honig P; Antal EJ; Bjornsson TD; Loh E
    Clin Pharmacol Ther; 2007 Aug; 82(2):137-42. PubMed ID: 17632539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation model-based drug discovery and development: quantitative and systems pharmacology.
    Allerheiligen SR
    Clin Pharmacol Ther; 2010 Jul; 88(1):135-7. PubMed ID: 20531467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economics of drug development: a grim reality and a role for clinical pharmacology.
    Honig P; Lalonde R
    Clin Pharmacol Ther; 2010 Mar; 87(3):247-51. PubMed ID: 20160740
    [No Abstract]   [Full Text] [Related]  

  • 6. An assessment of R&D productivity in the pharmaceutical industry.
    Dimitri N
    Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASCPT Task Force for advancing pharmacometrics and integration into drug development.
    Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A
    Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial simulation: a review.
    Holford N; Ma SC; Ploeger BA
    Clin Pharmacol Ther; 2010 Aug; 88(2):166-82. PubMed ID: 20613720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.
    Smith BP; Vincent J
    Clin Pharmacol Ther; 2010 Aug; 88(2):141-4. PubMed ID: 20648027
    [No Abstract]   [Full Text] [Related]  

  • 11. Paving the critical path: how can clinical pharmacology help achieve the vision?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Feb; 81(2):170-7. PubMed ID: 17259944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery: are productivity metrics inhibiting motivation and creativity?
    Ullman F; Boutellier R
    Drug Discov Today; 2008 Nov; 13(21-22):997-1001. PubMed ID: 18652910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmaceutical industry needs more clinical pharmacologists.
    Peck R
    Br J Clin Pharmacol; 2017 Nov; 83(11):2343-2346. PubMed ID: 28688130
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiscale modeling in drug discovery and development: future opportunities and present challenges.
    Vicini P
    Clin Pharmacol Ther; 2010 Jul; 88(1):126-9. PubMed ID: 20520608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probabilistic risk analysis: improving early drug development decision making.
    Mudd PN; Groenendaal H; Bush MA; Schmith VD
    Clin Pharmacol Ther; 2010 Dec; 88(6):871-5. PubMed ID: 20944562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value networks identify innovation in 21st century pharmaceutical research.
    Edwards PJ
    Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedside-to-bench pharmacology: a complementary concept to translational pharmacology.
    Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 2010 Jun; 87(6):647-9. PubMed ID: 20485323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical R&D: the road to positive returns.
    David E; Tramontin T; Zemmel R
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug development and the FDA's Critical Path Initiative.
    Woosley RL; Cossman J
    Clin Pharmacol Ther; 2007 Jan; 81(1):129-33. PubMed ID: 17186012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.